Stay Informed with the Latest Political News on Politics Affairs
TAIPEI,Nov. 14,2024-- Ubiquity Sprouting Corporation has achieved a major milestone in the plant-based milk industry,completing the prototype of its innovative germinated plant milk production equipme
Nov 15, 2024SINGAPORE,Nov. 14,2024-- BB Energy andSGTraDex renew strategic partnership to advance digital borrowing base financing across Asia. This continued collaboration underscores both companies\' commitment
Nov 15, 2024SAO PAULO,Nov. 14,2024-- Themed "Development and Revitalization: A New Journey for the Global South," the inaugural Global South Media and Think Tank Forum was held here from Monday to Tuesd
Nov 15, 2024OSAKA,Japan,Nov. 14,2024-- To build momentum for EXPO 2025Osaka-Kansai,a large-scale special event dubbed "Midosuji Runway 2024" was held along the Midosuji Avenue in Chuo Ward,Osaka,on Sund
Nov 15, 2024LA CHAUX-DE-FONDS,Switzerland,Nov. 14,2024-- Independent watch brand MING is thrilled to share that its 37.09 Bluefin dive watch has received the Sports Watch Prize at the 2024Grand Prix d\'Horlogerie
Nov 15, 2024Global client expansion and deepened partnerships drive Corero\'s continued growth in cyber defense. MARLBOROUGH,Mass.,Nov. 14,2024-- Corero Network Security (AIM: CNS) (OTCQX: DDOSF),the distributed
Nov 15, 2024GRONO,Switzerland,Nov. 14,2024-- By expanding its expertise and integrating several complementary competencies through both organic growth as well as mergers and acquisitions over the last few years,
Nov 15, 2024Revolutionizing results and transforming knowledge into power for enterprises Digital Twins support the optimization of business operations,enhancement of decision-making processes,and driving of sust
Nov 15, 2024GUANGZHOU,China,Nov. 14,2024-- On November 11th,Global Forum of University Presidents was successfully held at the Guangzhou Campus of Sun Yat-sen University (SYSU),as this prestigious university was
Nov 15, 2024Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data On track to dose first patient in randomized Phase 2 study ofuliledlimab in first-line mNSCLC in 1H 2025
Nov 15, 2024